Minimizing Side Effects One of the most frequently cited reasons for microdosing GLP-1 drugs, as mentioned above, is the desire to minimize side effects
Another novel glucose-lowering agent is tirzepatide which has a dual mechanism of action: a GLP-1 and a glucose-dependent insulinotropic polypeptide (GIP) co-agonist
This is a permanent augmentation option which can be reversed only through removal of the lip implant
Axonal Injury In experimental models, axonal damage has been found to be present acutely after TBI of all severities, with the regional distribution and the number of damaged axons increasing with injury severity
If you are travelling internationally, you may need to take your injection slightly earlier or later to maintain consistency with your new time zone
Oncogene , 36 (6), 863874